ANTIBODIES THAT NEUTRALIZE TYPE-I INTERFERON (IFN) ACTIVITY Read more about ANTIBODIES THAT NEUTRALIZE TYPE-I INTERFERON (IFN) ACTIVITY Patent Cooperation TreatyPCT/US2021/056067Filed on 2021-10-21
HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE Read more about HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE Ireland17784795.1Filed on 2017-10-03
HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE Read more about HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE United Kingdom17784795.1Filed on 2017-10-03
HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE Read more about HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE France17784795.1Filed on 2017-10-03
HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE Read more about HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE Germany17784795.1Filed on 2017-10-03
HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE Read more about HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE Switzerland17784795.1Filed on 2017-10-03
HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE Read more about HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE Belgium17784795.1Filed on 2017-10-03
Anti-Coronavirus Antibodies And Methods Of Use Read more about Anti-Coronavirus Antibodies And Methods Of Use Pakistan196/2021Filed on 2021-03-08
BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION Read more about BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION Hong Kong42021036522.7Filed on 2021-08-09
STABILIZED NOROVIRUS VIRUS-LIKE PARTICLES AS VACCINE IMMUNOGENS Read more about STABILIZED NOROVIRUS VIRUS-LIKE PARTICLES AS VACCINE IMMUNOGENS Patent Cooperation TreatyPCT/US2021/055018Filed on 2021-10-14